IVF
INVO Fertility, Inc.
Next earnings Aug 12, 2026 · consensus $-0.71 EPS, $2.42M rev
Last earnings -7.3% on 2026-06-22
$2.45
▲ +97.58%$2.45▼ -98.09%
over 1Y
L $1.24EODHDH $138.40
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+97.6%
1W+76.3%
1M+53.1%
3M-8.6%
YTD-45.6%
1Y-98.1%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 5 analysts
Buy
High return on equity (86.3%); but unprofitable (net margin -340.9%).
Revenue (FY2025) $6.84M · FY2025
INVO Fertility, Inc. shows $6.84M in FY2025 revenue (+4.7% YoY), a -340.9% net margin, and 86.3% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | $3.02M | $6.53M | $6.84M |
| Gross profit | $4.02M | $491K | — | — | — |
| Operating income | -$5.22M | -$10.6M | -$6.77M | -$6.63M | -$7.24M |
| Net income | -$6.65M | -$10.9M | -$8.03M | -$9.26M | -$23.3M |
| Diluted EPS | -$0.63 | -$17.97 | -$67.37 | -$3,782.65 | -$214.64 |
| Net margin | — | — | -266.0% | -141.7% | -340.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$710K
EV / EBITDA—
EV / Sales0.1
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-533.0%
FCF yield-161.3%
Quality & risk
ROIC (est.)—
Free cash flow-$7.06M
Total debt$2.02M
Net cash$3.67M
Altman Z-Score-7.37 distress
Piotroski F-Score3/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+67.5%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — restated periodic report (2026-06-12). Worth a closer look.
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-232026-06-25open ↗DEF 14APeriod ending 2026-06-232026-06-23open ↗8-KPeriod ending 2026-06-222026-06-22open ↗10-QPeriod ending 2026-03-312026-06-22open ↗8-KPeriod ending 2026-06-162026-06-16open ↗PRE 14APeriod ending 2026-06-122026-06-12open ↗10-K/APeriod ending 2025-12-312026-06-12open ↗8-KPeriod ending 2026-06-022026-06-02open ↗10-KPeriod ending 2025-12-312026-06-02open ↗8-KPeriod ending 2026-06-012026-06-02open ↗NT 10-QPeriod ending 2026-03-312026-05-18open ↗SCHEDULE 13G/AFiling2026-05-15open ↗
Frequently asked
- Is INVO Fertility, Inc. (IVF) a buy?
- IVF currently carries a Avoid rating with 2/5 conviction, derived from its latest SEC filings. High return on equity (86.3%); but unprofitable (net margin -340.9%).
- What is INVO Fertility, Inc.'s quality score?
- IVF scores 40.8235294117647/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001417926, latest 10-Q filed 2026-06-22) · EODHD · as of 6/22/2026, 9:49:05 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.